Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Non-Invasive Colorectal Cancer Screening

BACKGROUND: Biomarker assays could increase the accuracy of non-invasive detection of colorectal cancer (CRC); fecal immunochemical tests (FITs) are estimated to miss 27%–47% of CRCs and 70%–80% of advanced adenomas per round of screening. We investigated the conditions under which biomarker screens...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Gastroenterol Hepatol
Principais autores: Lansdorp-Vogelaar, Iris, Goede, S. Lucas, Bosch, Linda J.W., Melotte, Veerle, Carvalho, Beatriz, van Engeland, Manon, Meijer, Gerrit A., de Koning, Harry J., van Ballegooijen, Marjolein
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773413/
https://ncbi.nlm.nih.gov/pubmed/28733262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2017.07.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados